IN2014KN00796A - - Google Patents
Info
- Publication number
- IN2014KN00796A IN2014KN00796A IN796KON2014A IN2014KN00796A IN 2014KN00796 A IN2014KN00796 A IN 2014KN00796A IN 796KON2014 A IN796KON2014 A IN 796KON2014A IN 2014KN00796 A IN2014KN00796 A IN 2014KN00796A
- Authority
- IN
- India
- Prior art keywords
- cancer
- combinations
- oleanderthis
- neriumnerium
- cisplatin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161549386P | 2011-10-20 | 2011-10-20 | |
| PCT/US2012/061226 WO2013059753A1 (en) | 2011-10-20 | 2012-10-20 | Therapeutic combination for the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014KN00796A true IN2014KN00796A (sv) | 2015-10-02 |
Family
ID=48141445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN796KON2014 IN2014KN00796A (sv) | 2011-10-20 | 2012-10-20 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20130209579A1 (sv) |
| EP (2) | EP3711754A1 (sv) |
| JP (1) | JP6255346B2 (sv) |
| CN (2) | CN110269940A (sv) |
| AU (3) | AU2012325819B2 (sv) |
| BR (1) | BR112014009421A2 (sv) |
| CA (1) | CA2852274C (sv) |
| GT (1) | GT201400071A (sv) |
| IL (2) | IL231987B (sv) |
| IN (1) | IN2014KN00796A (sv) |
| MX (2) | MX365635B (sv) |
| RU (2) | RU2014120179A (sv) |
| WO (1) | WO2013059753A1 (sv) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2346518B1 (en) * | 2008-10-14 | 2020-09-02 | Nerium Biotechnology, Inc. | Process for extracting cardiac glycosides from nerium oleander and compositions |
| CN107530309A (zh) * | 2015-04-22 | 2018-01-02 | 新纳特产品公司 | 共晶组合物及其药物用途 |
| WO2017060661A1 (en) * | 2015-10-05 | 2017-04-13 | Nucana Biomed Limited | Combination therapy |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI872106A (fi) | 1986-05-13 | 1987-11-14 | Huseyin Ziya Ozel | Extrakt av nerium-arter, foerfarande foer framstaellning av dem och deras anvaendning. |
| AU6056999A (en) | 1998-09-24 | 2000-04-10 | Ozelle Pharmaceuticals, Inc. | Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof |
| US7407675B2 (en) * | 2002-12-27 | 2008-08-05 | The Trustees Of Columbia University In The City Of New York | Anti-neoplastic compositions comprising extracts of black cohosh |
| US20060205679A1 (en) * | 2004-10-22 | 2006-09-14 | Azaya Therapeutics, Inc. | Topical and oral formulations of cardiac glycosides for treating skin diseases |
| US7402325B2 (en) | 2005-07-28 | 2008-07-22 | Phoenix Biotechnology, Inc. | Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander |
| EP1803461A1 (en) * | 2005-12-27 | 2007-07-04 | Heinz-Herbert Fiebig | Therapeutic use of an extract from the leaves of Nerium oleander |
| EP2668949A1 (en) | 2007-08-06 | 2013-12-04 | Ohio University | Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin |
| EP2346518B1 (en) | 2008-10-14 | 2020-09-02 | Nerium Biotechnology, Inc. | Process for extracting cardiac glycosides from nerium oleander and compositions |
-
2012
- 2012-10-20 CN CN201910226194.XA patent/CN110269940A/zh active Pending
- 2012-10-20 EP EP20159407.4A patent/EP3711754A1/en not_active Withdrawn
- 2012-10-20 BR BR112014009421A patent/BR112014009421A2/pt not_active Application Discontinuation
- 2012-10-20 RU RU2014120179/15A patent/RU2014120179A/ru unknown
- 2012-10-20 AU AU2012325819A patent/AU2012325819B2/en not_active Ceased
- 2012-10-20 IN IN796KON2014 patent/IN2014KN00796A/en unknown
- 2012-10-20 MX MX2014004527A patent/MX365635B/es active IP Right Grant
- 2012-10-20 WO PCT/US2012/061226 patent/WO2013059753A1/en active Application Filing
- 2012-10-20 EP EP12841023.0A patent/EP2768498B1/en active Active
- 2012-10-20 JP JP2014537346A patent/JP6255346B2/ja not_active Expired - Fee Related
- 2012-10-20 CA CA2852274A patent/CA2852274C/en not_active Expired - Fee Related
- 2012-10-20 RU RU2017136415A patent/RU2017136415A/ru not_active Application Discontinuation
- 2012-10-20 CN CN201280051254.5A patent/CN104093405A/zh active Pending
-
2013
- 2013-03-15 US US13/838,739 patent/US20130209579A1/en not_active Abandoned
-
2014
- 2014-04-07 IL IL231987A patent/IL231987B/en not_active IP Right Cessation
- 2014-04-14 MX MX2019006685A patent/MX2019006685A/es unknown
- 2014-04-15 GT GT201400071A patent/GT201400071A/es unknown
-
2017
- 2017-10-31 AU AU2017254875A patent/AU2017254875A1/en not_active Abandoned
-
2019
- 2019-05-21 AU AU2019203577A patent/AU2019203577A1/en not_active Abandoned
- 2019-05-22 US US16/419,226 patent/US20190343908A1/en not_active Abandoned
-
2020
- 2020-06-24 IL IL275636A patent/IL275636A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GT201400071A (es) | 2015-09-17 |
| IL231987A0 (en) | 2014-05-28 |
| AU2012325819B2 (en) | 2017-08-03 |
| BR112014009421A2 (pt) | 2017-04-18 |
| IL275636A (en) | 2020-08-31 |
| US20190343908A1 (en) | 2019-11-14 |
| CN104093405A (zh) | 2014-10-08 |
| MX2014004527A (es) | 2014-09-15 |
| AU2012325819A1 (en) | 2014-04-24 |
| MX2019006685A (es) | 2019-08-21 |
| RU2017136415A (ru) | 2019-02-08 |
| IL231987B (en) | 2020-07-30 |
| JP2014530878A (ja) | 2014-11-20 |
| CA2852274A1 (en) | 2013-04-25 |
| AU2017254875A1 (en) | 2017-11-23 |
| RU2017136415A3 (sv) | 2021-02-08 |
| CN110269940A (zh) | 2019-09-24 |
| EP2768498A1 (en) | 2014-08-27 |
| NZ623550A (en) | 2016-06-24 |
| US20130209579A1 (en) | 2013-08-15 |
| EP2768498A4 (en) | 2015-06-17 |
| RU2014120179A (ru) | 2015-11-27 |
| WO2013059753A1 (en) | 2013-04-25 |
| JP6255346B2 (ja) | 2017-12-27 |
| CA2852274C (en) | 2019-08-06 |
| EP3711754A1 (en) | 2020-09-23 |
| AU2019203577A1 (en) | 2019-06-13 |
| MX365635B (es) | 2019-06-10 |
| EP2768498B1 (en) | 2020-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12015501744B1 (en) | Therapeutic and diagnostic target for cancer comprising dll3 binding reagents | |
| MX360404B (es) | Compuestos para inhibir la proliferacion celular en canceres transmitidos por egfr. | |
| MX2015007185A (es) | Uso de eribulina en el tratamiento de cancer de pecho. | |
| SA515360657B1 (ar) | مثبطات ديميثيلاز هيستون | |
| MX366804B (es) | Translocaciones de la r-espondina y sus metodos de uso. | |
| EA201290901A1 (ru) | Фитоканнабиноиды для лечения злокачественной опухоли | |
| MX2016002051A (es) | Metodos y kits para la subtipificacion molecular de tumores. | |
| MX2013002084A (es) | Biomarcadores y metodos de tratamiento. | |
| MX360141B (es) | Anticuerpos contra integrina alfavhbeta6 y uso de los mismos para tratar cancer. | |
| EA201201000A1 (ru) | Способы лечения колоректального рака | |
| WO2012122295A3 (en) | Treatment for pancreatic adenocarcinoma and other cancers of epithelial origin | |
| MX2015014046A (es) | Combinaciones de farmacos para tratar cancer. | |
| MA33973B1 (fr) | Méthodes de traitement du cancer à l'aide d'antagonistes de notch | |
| MX336761B (es) | Compuestos para el tratamiento de cancer. | |
| EA201370071A1 (ru) | Способы и композиции для лечения рака легких | |
| MX2019006331A (es) | Métodos para tratar el cáncer usando anticuerpos anti-pd-l1 y antiandrógenos. | |
| MX2013015340A (es) | Composiciones y metodos para el tratamiento de cancer. | |
| EA201790502A1 (ru) | Ингибиторы гистоновых диметилаз | |
| CR20110479A (es) | Combinaciones farmaceuticas que comprenden rdea 119/bay 869766 para el tratamiento de canceres especificos | |
| NZ703411A (en) | Use of markers in the diagnosis and treatment of prostate cancer | |
| FR2945210B1 (fr) | Combinaison antitumorale comprenant l'ave8062 et le sorafenib | |
| PH12015502757A1 (en) | Combinations for the treatment of cancer comprising a mps-1 kinase inhibitor and a mitotic inhibitor | |
| WO2013188750A3 (en) | Substituted macrocyclic compounds having proteasome inhibitory activity | |
| WO2013081645A3 (en) | Erbb3 mutations in cancer | |
| IN2014KN00796A (sv) |